Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001571049-16-013493
Filing Date
2016-03-30
Accepted
2016-03-30 17:20:53
Documents
5
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT t1600894_pre14a.htm PRE 14A 395661
2 GRAPHIC t1600894_pc-pg01.jpg GRAPHIC 320375
3 GRAPHIC t1600894_pc-pg02.jpg GRAPHIC 252634
4 GRAPHIC t1600894_pc-pg03.jpg GRAPHIC 250073
5 GRAPHIC t1600894_pc-pg04.jpg GRAPHIC 198989
  Complete submission text file 0001571049-16-013493.txt   1788596
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50626 | Film No.: 161540804
SIC: 2834 Pharmaceutical Preparations